Avedro Inc (AVDR)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

201 JONES ROAD WALTHAM, MA 02451

Avedro, Inc. provides medical devices and pharmaceutical products. The Company offers ophthalmic solutions and systems, as well as drugs. Avedro serves customers worldwide.

Data as of 2019-12-03 06:25:56 -0500
Market Cap402.808 Million Shares Outstanding17.521 Million Avg 30-day Volume
P/E Ratio Dividend Yield EPS-2.316
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low27.51 / 10.75 Next Earnings Date Price to Cash FLow (P/CF)
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from AVDR instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AVDR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AVDR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PALMISANO ROBERT J

  • Director
No longer subject to file 2019-11-21 0

SILVERSTEIN JONATHAN

  • Director
  • 10% Owner
No longer subject to file 2019-11-21 0

ZURBAY DONALD

  • Director
No longer subject to file 2019-11-21 0

BAVIER PAUL S GENERAL COUNSEL AND SEC.

  • Officer
No longer subject to file 2019-11-21 0

FIRST DAVID CHIEF HUMAN RESOURCES OFFICER

  • Officer
No longer subject to file 2019-11-21 0

GRIFFIN THOMAS E CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2019-11-21 0

KONG GARHENG

  • Director
No longer subject to file 2019-11-21 0

LU HONGBO

  • Director
No longer subject to file 2019-11-21 0

RAJPAL RAJESH K. CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2019-11-21 0

SCHUERMANN JAMES CHIEF BUSINESS OFFICER

  • Officer
No longer subject to file 2019-11-21 0

ZADNO REZA PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2019-11-21 0

INTERWEST PARTNERS X LP

INTERWEST MANAGEMENT PARTNERS X, LLC

ORONSKY ARNOLD L

NASR KHALED

DESAI KEVAL

KLIMAN GILBERT H

  • 10% Owner
No longer subject to file 2019-11-21 0

KLIMAN GILBERT H

  • Director
  • 10% Owner
0 2019-06-14 0

BURNS THOMAS WILLIAM

  • Director
0 2019-06-14 0

ORBIMED ADVISORS LLC

ORBIMED ROF II LLC

ORBIMED CAPITAL GP VI LLC

  • 10% Owner
4,240,128 2019-02-19 0

INTERWEST PARTNERS X LP

ORONSKY ARNOLD L

DESAI KEVAL

NASR KHALED

INTERWEST MANAGEMENT PARTNERS X, LLC

  • 10% Owner
2,742,239 2019-02-19 0

HEALTHQUEST PARTNERS II, L.P.

HEALTHQUEST VENTURE MANAGEMENT II, L.L.C.

  • 10% Owner
109,534 2019-02-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments